85S-16069-92259 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-11
Dose 1 — Pfizer-BioNTech
2021-06-01
Dose 2 — Pfizer-BioNTech
2021-06-02
Registered in v-safe
2021-06-02
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-06-03
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-06-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-06-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-06-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2022-06-01
Survey response — 12 months, dose 2
MedDRA: Office visit, Vestibular migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Vestibular migraine · Healthcare visit (other): Specialist appointment and testing

MedDRA releases: 2024-11 · check-in free text available
2022-06-01
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2022-06-02
Call 1 — Could Not Reach Participant
2022-06-07
Call 2 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-11	Pfizer-BioNTech
2	2021-06-01	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — 12 months, dose 2

2022-06-01

Symptoms: Vestibular migraine

Healthcare visit (other): Specialist appointment and testing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Vestibular migraine	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release